Welcome to LookChem.com Sign In|Join Free
  • or
Home > Products >  > 

Etretinate

Related Products

Hot Products

Name

Etretinate

EINECS 259-119-3
CAS No. 54350-48-0 Density 1.006 g/cm3
PSA 35.53000 LogP 5.64550
Solubility N/A Melting Point 104-105 °C
Formula C23H30O3 Boiling Point 506.4 °C at 760 mmHg
Molecular Weight 354.489 Flash Point 219.4 °C
Transport Information N/A Appearance Crystalline solid
Safety Risk Codes N/A
Molecular Structure Molecular Structure of 54350-48-0 (Etretinate) Hazard Symbols N/A
Synonyms

2,4,6,8-Nonatetraenoicacid, 9-(4-methoxy-2,3,6-trimethylphenyl)-3,7-dimethyl-, ethyl ester, (all-E)-;Ethylall-trans-9-(4-methoxy-2,3,6-trimethylphenyl)-3,7-dimethyl-2,4,6,8-nonatetraenoate;Ethyl etrinoate;Etretinate;Ro 10-9359;Tegison;Tigason;Tigasone;

Article Data 9

Etretinate Consensus Reports

EPA Genetic Toxicology Program.

Etretinate Specification

The Etretinate is an organic compound with the formula C23H30O3. The IUPAC name of this chemical is ethyl (2E,4E,6E,8E)-9-(4-methoxy-2,3,6-trimethylphenyl)-3,7-dimethylnona-2,4,6,8-tetraenoate. With the CAS registry number 54350-48-0, it is also named as Tigason. The product's categories are Aromatics Compounds; Aromatics; Intermediates & Fine Chemicals; Pharmaceuticals; Retinoids; API. Besides, it is a crystalline solid, which is used to treat severe psoriasis.

Physical properties about Etretinate are: (1)ACD/LogP: 6.77; (2)# of Rule of 5 Violations: 1; (3)ACD/LogD (pH 5.5): 6.77; (4)ACD/LogD (pH 7.4): 6.77; (5)ACD/BCF (pH 5.5): 82447.64; (6)ACD/BCF (pH 7.4): 82447.64; (7)ACD/KOC (pH 5.5): 114968.87; (8)ACD/KOC (pH 7.4): 114968.87; (9)#H bond acceptors: 3; (10)#Freely Rotating Bonds: 8; (11)Polar Surface Area: 35.53 Å2; (12)Index of Refraction: 1.544; (13)Molar Refractivity: 111.25 cm3; (14)Molar Volume: 352.2 cm3; (15)Polarizability: 44.1×10-24cm3; (16)Surface Tension: 34.9 dyne/cm; (17)Density: 1.006 g/cm3; (18)Flash Point: 219.4 °C; (19)Enthalpy of Vaporization: 77.63 kJ/mol; (20)Boiling Point: 506.4 °C at 760 mmHg; (21)Vapour Pressure: 2.22E-10 mmHg at 25°C.

You can still convert the following datas into molecular structure:
(1)SMILES: O=C(OCC)C=C(C=CC=C(C=Cc1c(cc(OC)c(c1C)C)C)C)C
(2)InChI: InChI=1/C23H30O3/c1-8-26-23(24)14-17(3)11-9-10-16(2)12-13-21-18(4)15-22(25-7)20(6)19(21)5/h9-15H,8H2,1-7H3
(3)InChIKey: HQMNCQVAMBCHCO-UHFFFAOYAW
(4)Std. InChI: InChI=1S/C23H30O3/c1-8-26-23(24)14-17(3)11-9-10-16(2)12-13-21-18(4)15-22(25-7)20(6)19(21)5/h9-15H,8H2,1-7H3
(5)Std. InChIKey: HQMNCQVAMBCHCO-UHFFFAOYSA-N

The toxicity data is as follows:

Organism Test Type Route Reported Dose (Normalized Dose) Effect Source
human TDLo oral 78mg/kg/26W-I (78mg/kg) SKIN AND APPENDAGES (SKIN): "DERMATITIS, OTHER: AFTER SYSTEMIC EXPOSURE"

SKIN AND APPENDAGES (SKIN): HAIR: OTHER

SKIN AND APPENDAGES (SKIN): NAILS: OTHER
Arzneimittel-Forschung. Drug Research. Vol. 32, Pg. 842, 1982.
man TDLo oral 1136mg/kg/9Y- (1136mg/kg) SENSE ORGANS AND SPECIAL SENSES: OTHER: EYE Lancet. Vol. 1, Pg. 235, 1988.
mouse LD50 intraperitoneal 1gm/kg (1000mg/kg)   United States Patent Document. Vol. #4105681,
mouse LD50 oral > 2gm/kg (2000mg/kg)   Journal of the American Academy of Dermatology. Vol. 6, Pg. 652, 1982.
mouse LD50 subcutaneous > 1gm/kg (1000mg/kg)   Drugs in Japan Vol. -, Pg. 191, 1990.
rabbit LD50 oral > 2gm/kg (2000mg/kg)   Journal of the American Academy of Dermatology. Vol. 6, Pg. 652, 1982.
rat LD50 intraperitoneal > 1gm/kg (1000mg/kg) SKIN AND APPENDAGES (SKIN): HAIR: OTHER Yakuri to Chiryo. Pharmacology and Therapeutics. Vol. 10, Pg. 5033, 1982.
rat LD50 oral > 4gm/kg (4000mg/kg) BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY)

GASTROINTESTINAL: "HYPERMOTILITY, DIARRHEA"

SKIN AND APPENDAGES (SKIN): HAIR: OTHER
Yakuri to Chiryo. Pharmacology and Therapeutics. Vol. 10, Pg. 5033, 1982.
rat LD50 subcutaneous > 1gm/kg (1000mg/kg)   Yakuri to Chiryo. Pharmacology and Therapeutics. Vol. 10, Pg. 5033, 1982.
women TDLo oral 80ug/kg/8D-I (0.08mg/kg) LIVER: OTHER CHANGES

SKIN AND APPENDAGES (SKIN): "DERMATITIS, OTHER: AFTER SYSTEMIC EXPOSURE"
British Journal of Dermatology. Vol. 112, Pg. 373, 1985.
women TDLo oral 60mg/kg/17W-I (60mg/kg) SKIN AND APPENDAGES (SKIN): HAIR: OTHER CUTIS; Cutaneous Medicine for the Practitioner. Vol. 35, Pg. 466, 1985.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 54350-48-0